AstraZeneca makes surprise U-turn with £300m pharma investment
Drugmaker had stalled large-scale UK projects but has now pledged investment at two sites, announced by Keir Starmer
Britain’s biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year.
The drugmaker had pulled back projects in Britain after becoming disillusioned with the business environment, including the availability of new medicines on the NHS and drug pricing.
https://www.theguardian.com/business/2026/apr/29/astrazeneca-makes-surprise-u-turn-with-300m-pharma-investment">Continue reading...AstraZeneca beats expectations
- UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies CNBC —
- Astrazeneca tops expectations in the first quarter on strong cancer drug sales Associated Press —
- AstraZeneca posted stronger-than-expected profit and revenue on surging cancer drug sales Quartz —
- Shot in the arm for GSK and AstraZeneca from cancer drug sales The Argus —
- Astrazeneca ploughs £300m into UK in surprise U-turn City AM —